Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.19 is 112% above its 5-year average of 3.40, near the high end of its 5-year range (1.01–7.49).
As of the fiscal period ended Tuesday, June 30, 2026. 50.53% above its 12-month average of 4.78.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.19.
CURRENT RATIO
7.19
CURRENT RATIO AVG TTM
4.78
CURRENT RATIO AVG 3Y
4.51
CURRENT RATIO AVG 5Y
3.40
CURRENT RATIO AVG 10Y
2.45
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+50.53%
CURRENT VS 3Y AVG
+59.51%
CURRENT VS 5Y AVG
+111.68%
CURRENT VS 10Y AVG
+193.54%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 513 covered companies
CURRENT VS SECTOR MEDIAN
+114.66%
vs the sector median at left
Aquestive Therapeutics, Inc.
Market Cap
$579.66M
Current Ratio
7.19
TTM Avg
4.78
3Y Avg
4.51
5Y Avg
3.40
Market Cap
$583.37M
Current Ratio
5.42
TTM Avg
12.18
3Y Avg
12.18
5Y Avg
12.18
Market Cap
$589.38M
Current Ratio
3.46
TTM Avg
4.63
3Y Avg
6.00
5Y Avg
6.13
Market Cap
$568.20M
Current Ratio
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
Market Cap
$598.37M
Current Ratio
6.06
TTM Avg
2.91
3Y Avg
9.31
5Y Avg
9.54
Market Cap
$554.90M
Current Ratio
25.13
TTM Avg
6.17
3Y Avg
7.34
5Y Avg
19.91
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | $579.66M | 7.19 | 4.78 | 4.51 | 3.40 |
| CorMedix Inc. (CRMD)vs › | $578.97M | 2.56 | 2.75 | 5.48 | 7.66 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $583.37M | 5.42 | 12.18 | 12.18 | 12.18 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $589.38M | 3.46 | 4.63 | 6.00 | 6.13 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $568.20M | 9.36 | 2.17 | 1.76 | 2.63 |
| OrthoPediatrics Corp. (KIDS)vs › | $595.38M | 4.78 | 6.27 | 6.33 | 5.72 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $598.37M | 6.06 | 2.91 | 9.31 | 9.54 |
| Immix Biopharma, Inc. (IMMX)vs › | $554.90M | 25.13 | 6.17 | 7.34 | 19.91 |
| Delcath Systems, Inc. (DCTH)vs › | $549.24M | 9.83 | 11.46 | 6.57 | 5.79 |
| Crescent Biopharma, Inc. (CBIO)vs › | $548.99M | 9.66 | 5.09 | 5.58 | 6.85 |
Current Ratio
7.19
Quick Ratio
6.74
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.19 |
| 2026-03-31 | 4.10 |
| 2025-12-31 | 3.14 |
| 2025-09-30 | 5.93 |
| 2025-06-30 | 3.53 |
| 2025-03-31 | 4.87 |
| 2024-12-31 | 4.68 |
| 2024-09-30 | 6.37 |
| 2024-06-30 | 7.49 |
| 2024-03-31 | 6.28 |
| 2023-12-31 | 2.24 |
| 2023-09-30 | 1.76 |
| 2023-06-30 | 1.03 |
| 2023-03-31 | 1.08 |
| 2022-12-31 | 1.01 |
| 2022-09-30 | 1.04 |
| 2022-06-30 | 1.47 |
| 2022-03-31 | 1.76 |
| 2021-12-31 | 2.15 |
| 2021-09-30 | 2.01 |
| 2021-06-30 | 2.21 |
| 2021-03-31 | 2.22 |
| 2020-12-31 | 2.11 |
| 2020-09-30 | 1.72 |
| 2020-06-30 | 2.95 |
| 2020-03-31 | 3.33 |
| 2019-12-31 | 3.68 |
| 2019-09-30 | 1.90 |
| 2019-06-30 | 1.59 |
| 2019-03-31 | 1.89 |
| 2018-12-31 | 2.25 |
| 2018-09-30 | 3.63 |
| 2018-06-30 | 1.14 |
| 2018-03-31 | 1.30 |
| 2017-12-31 | 1.83 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
